TUL Animal Protection has regained the national invention patent TUL Tazosin ® Evaluate the consiste

Recently, TUL obtained the Notice of Approval of Supplementary Application for Drugs issued by the State Food and Drug Administration, approving piperacillin sodium and tazobactam sodium for injection (specification: 4.5g, trademark: TUL tazobactam ®） Evaluate the consistency of generic drug quality and efficacy (acceptance number: CYHB2150732 country).

Piperacillin sodium and tazobactam sodium for injection of TUL are composed of penicillin antibacterial drugs piperacillin and β- The compound medicine composed of tazobactam, an inhibitor of lactam enzyme, is suitable for treating moderate to severe infections caused by pneumonia, urinary tract infection, skin and soft tissue infection, sepsis, endometritis or pelvic inflammation, bone and joint infection, etc.

Piperacillin sodium and tazobactam sodium for injection is one of the key products of the United Laboratories. Since its launch in 1999, it has clear clinical efficacy, safety and reliability. This product has been included in the national basic drug (2018 version) and national medical insurance (2021 version) Class B drugs.

The research team of TUL has carried out rigorous research on this product according to the latest technical requirements, with stable process and controllable quality. This review has further improved the TUL tazosin ® Market competitiveness.